文献速递细菌感染、耐药与抗菌药物

日本2013年全国监测中淋病奈瑟菌分子特征:易感谱系出现头孢曲松耐药株

Molecular characterization of Neisseria gonorrhoeae isolates collected through a national surveillance programme in Japan, 2013: evidence of the emergence of a ceftriaxone-resistant strain from a ceftriaxone-susceptible lineage.
PubMed 文献 · J Antimicrob Chemother · 2021-01-01

该研究对2013年日本全国监测收集的55株淋病奈瑟菌进行药敏试验和全基因组测序,发现头孢克肟敏感率58%、头孢曲松敏感率98%。未检出H041和FC428株,但鉴定出一株头孢曲松耐药株TUM15748(MIC 0.5 mg/L),属于MLST-ST7359,具有新型PBP2镶嵌型(penA 169.001)。转化实验表明该penA可使头孢曲松MIC提高16倍以上,提示易感谱系通过重组共生奈瑟菌部分PBP2序列获得耐药。

要点

  • 2013年日本55株淋球菌中头孢曲松敏感率98%,头孢克肟敏感率58%。
  • 检出1株头孢曲松耐药株TUM15748(MIC 0.5 mg/L),属MLST-ST7359,此前无该ST耐药报道。
  • TUM15748的penA(169.001)可使受体菌头孢曲松MIC提高16倍以上。

核心结论

  • 头孢曲松易感谱系MLST-ST7359通过获取含共生奈瑟菌部分PBP2序列的镶嵌型penA,导致头孢曲松耐药株出现。

研究设计与样本

  • 研究对2013年日本全国监测收集的55株淋病奈瑟菌进行了药敏试验和全基因组测序。

主要发现

  • 头孢克肟敏感率为58%,头孢曲松敏感率为98%。
  • 55株菌分为9个MLST-ST,最常见为ST1901(n=19),其次ST7363(n=12)和ST7359(n=11)。
  • 最常见penA镶嵌型为10.001(n=20),其次34.001(n=13)。
  • 未检出H041和FC428株,但发现1株头孢曲松耐药株TUM15748(MIC 0.5 mg/L),属MLST-ST7359和NG-MAST-ST6771,具有新型PBP2(penA 169.001)。
  • 使用全长TUM15748 penA进行转化实验,转化子头孢曲松MIC较易感受体菌NG9807(MLST-ST7363)提高16倍或以上。

临床怎么用

  • 淋球菌耐药监测中应关注头孢曲松MIC升高及新型penA镶嵌型,尤其MLST-ST7359谱系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To investigate the spread of ceftriaxone-resistant Neisseria gonorrhoeae lineages similar to strains H041 (2009) and FC428 (2015), we characterized 55 strains collected in 2013 from hospitals across Japan. METHODS: Susceptibility testing and whole-genome sequencing. RESULTS: Susceptibility rates were 58% for cefixime and 98% for ceftriaxone. The 55 strains were whole-genome sequenced and classified into nine MLST-STs. MLST-ST1901 was the most prevalent (n = 19) followed by MLST-ST7363 (n = 12) and MLST-ST7359 (n = 11). The most prevalent penA [encoding penicillin binding protein 2 (PBP2)] mosaic types, based on the N. gonorrhoeae sequence typing for antimicrobial resistance (NG-STAR) scheme, were 10.001 (n = 20) followed by 34.001 (n = 13). The H041 and FC428 strains were not detected; however, a single ceftriaxone-resistant strain (TUM15748) with a MIC of 0.5 mg/L ceftriaxone was identified. The TUM15748 strain belonged to MLST-ST7359 and N. gonorrhoeae multiantigen sequence typing-ST6771, and had a novel PBP2 (PBP2TUM15748, penA type 169.001). The amino acid sequence of PBP2TUM15748 showed partial similarity to that of PBP2 from N. gonorrhoeae GU140106 and commensal Neisseria perflava and Neisseria cinerea. Natural transformation and recombination experiments using full-length TUM15748 penA showed that the ceftriaxone MICs of transformants increased 16-fold or more compared with the parental ceftriaxone-susceptible recipient strain (NG9807, belonging to MLST-ST7363). No ceftriaxone-resistant MLST-ST7359 strains have previously been reported. CONCLUSIONS: We showed here that a ceftriaxone-susceptible lineage acquired a mutant PBP2 mosaic type, integrating partial PBP2 sequences from commensal Neisseria species, resulting in the emergence of ceftriaxone-resistant strains.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Hanao M, Aoki K, Ishii Y, et al. Molecular characterization of Neisseria gonorrhoeae isolates collected through a national surveillance programme in Japan, 2013: evidence of the emergence of a ceftriaxone-resistant strain from a ceftriaxone-susceptible lineage. J Antimicrob Chemother. 2021. PMID: 33930160. doi:10.1093/jac/dkab104

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。